Witryna4 cze 2004 · Melphalan is a direct-acting alkylating substance used as a therapeutic agent mainly in the treatment of breast and ovarian cancer and multiple myeloma [1]. It is a potent inducer of chromosomal aberrations and micronuclei in bone marrow cells [2] and it is known to be carcinogenic in rats, mice and humans [3]. Witryna7 gru 2009 · High-dose melphalan (HDM) is an essential component in the treatment of patients with multiple myeloma (MM). Few data are available regarding genetic polymorphisms associated with patient outcome ...
Pharmaceuticals - NCBI Bookshelf
Witryna31 gru 2014 · Melphalan has been shown to cause genotoxic effects and it has been classified by International Agency for Research of Cancer as an agent carcinogenic to humans (Group 1). Discover the world's... Witryna12 sie 2024 · Autologous hematopoietic cell transplantation (auto-HCT) using melphalan is the standard of care in the management of myeloma. Auto-HCT is a safe procedure with tolerable toxicity except in Asian ... pilot stations near me
Melphalan/TBI is not more carcinogeneic than …
WitrynaIARC monographs. Group 1: carcinogenic. Group 2A: probably carcinogenic. Group 2B: possibly carcinogenic. Group 3: not classifiable. Group 4: probably not carcinogenic. Substances, mixtures, and exposure circumstances in this list have been classified as group 1 by the International Agency for Research on Cancer (IARC): [1] … WitrynaMelphalan/TBI is not more carcinogeneic than cyclophosphamide/TBI for transplant conditioning: follow-up of 725 patients from a single centre over a period of 26 years … Witryna27 paź 2024 · possibly carcinogenic (319 agents) ... certain chemotherapy drugs like cyclophosphamide and melphalan; radiation therapy; tamoxifen, a drug that’s used to treat or prevent breast cancer; pilot status red blinking water heater